Global ENT Devices Market Size (2024 - 2029)

The ENT devices market is anticipated to experience significant growth due to the increasing prevalence of ear, nose, and throat-related disorders, alongside a rising adoption of minimally invasive procedures and technological advancements. The market size is expected to expand as the demand for ENT devices rises, driven by factors such as the impact of COVID-19 on ENT infections and the delayed diagnosis and treatment of ENT diseases during the pandemic. Despite challenges like high costs and social stigma, the market is poised to regain its potential and witness substantial growth over the forecast period.

Market Size of Global ENT Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
ENT Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.40 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

ENT Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

ENT Devices Market Analysis

The ENT Devices Market is projected to register a CAGR of 6.4% during the forecast period, 2022-2027.

The Pandemic has had ramifications for ways of working, of various ear, nose, throat (ENT) surgical and diagnostics procedures including minimally invasive procedures. According to the study titled "ENT Symptomology in Active COVID-19 Patients in our Tertiary Care Centre" published in August 2021, Anosmia and dysgeusia are significantly linked to COVID-19 disease, the nasal cavity has a higher viral concentration than the throat. Additionally, paucisymptomatic and asymptomatic COVID-19-positive patients have reported anosmia and dysgeusia. Thus, the rise in ENT infection in COVID-19 patient drive the demand for ENT devices. Moreover, due to the lockdown, a delay in diagnosis and treatments are being observed in patients with ENT diseases because of a reduction in hospital visits, and also many hospitals are trying to conserve the resources in treating COVID-19 patients who are declining the diagnosis of ENT diseases. THowever, with the ongoing vaccinations and decreasing COVID-19 cases, the ENT devices market is expected to regain its full potential over the forecast period.

The major factors for the growth of the ENT devices market include the increasing prevalence of ear, nose, and throat-related disorders, rising adoption of minimally invasive ENT procedures, and technological advancements. Sinusitis is one of the medical conditions wherein the cavities around the nasal passages (sinuses) are inflamed or swollen for more than twelve weeks. According to the study titled " Odontogenic Sinusitis: From Diagnosis to Treatment Possibilities-A Narrative Review of Recent Data" published in the MDPI Diagnosis, In Jun 2022, in the United States, sinusitis costs about USD 6 billion annually, plus USD 2 billion for over-the-counter remedies, with a prevalence rate of 10.4% in Europe and 14.0% in the United States. Also, more than 0.5 million surgeries for the treatment of chronic sinusitis are performed in the United States every year.

Also, according to the Action on Hearing Loss Information in April 2022, one out of every six people or over 10 million people in the United Kingdom suffer from hearing loss. Out of these, 6.4 million people belonged to the age group of 65 and above and 800,000 people suffered from severe or profound deafness. As the prevalence of hearing loss increased in the country the demand for the ENT devices is expected to increase over the forecast period, thereby boosting the market growth. Furthermore, according to the data published by the American Cancer Society April 2021, about 2,000 people in the United States develop cancers of the nasal cavity and paranasal sinuses each year. These cases are most common in the geriatric population. Thus, owing to the rising prevalence and new cases of ear, nose, and throat related disorders, the ENT devices market is expected to witness a high growth over the forecast period. However, high procedures and treatment cost and social stigma restrain the market growth over the forecast period.

ENT Devices Industry Segmentation

As per the scope of the report, ENT devices refer to special equipment used for detection, therapy, or surgery of any disorders related to the ear, nose, or throat. They also refer to synthetic materials and prosthetic devices used to restore any dysfunction of an ear, nose, or throat, and aid in correcting any problems with hearing, smelling or speaking. The ENT Devices Market is segmented by Product (Diagnostic Devices, Surgical Devices, Hearing Aids, Image-guided Surgery Systems, and Other Products), End User (Hospitals, ENT Clinics, and Other End User) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Diagnostic Devices
Surgical Devices
Hearing Aids
Image-guided Surgery Systems
Other Products
By End User
Hospitals
ENT Clinics
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global ENT Devices Market Size Summary

The ENT devices market is poised for significant growth, driven by the increasing prevalence of ear, nose, and throat disorders and the rising adoption of minimally invasive procedures. The market's expansion is further supported by technological advancements and the growing demand for devices such as hearing aids, which are essential for individuals with hearing loss. The COVID-19 pandemic has influenced the market dynamics, with a temporary decline in diagnoses and treatments due to reduced hospital visits. However, as vaccination rates increase and COVID-19 cases decrease, the market is expected to regain its momentum. The prevalence of conditions like sinusitis and hearing loss, particularly among the aging population, is expected to fuel the demand for ENT devices, thereby boosting market growth over the forecast period.

North America is anticipated to maintain a dominant position in the ENT devices market, supported by a high burden of ENT disorders and favorable healthcare infrastructure. The region's market growth is bolstered by the presence of major industry players and increased awareness of the benefits of ENT device solutions. The market is characterized by a few key players who focus on research and development to introduce innovative products, creating high entry barriers for new entrants. Product launches and advancements, such as AI-powered technologies and battery-free hearing aids, are expected to further propel market growth. Despite challenges like high treatment costs and social stigma, the market's trajectory remains positive, with ongoing innovations and strategic expansions by leading companies.

Explore More

Global ENT Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Ear, Nose, and Throat Related Disorders

      2. 1.2.2 Rising Adoption of Minimally Invasive ENT Procedures

      3. 1.2.3 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Procedure and Instruments Cost

      2. 1.3.2 Social Stigma

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product

      1. 2.1.1 Diagnostic Devices

      2. 2.1.2 Surgical Devices

      3. 2.1.3 Hearing Aids

      4. 2.1.4 Image-guided Surgery Systems

      5. 2.1.5 Other Products

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 ENT Clinics

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global ENT Devices Market Size FAQs

The Global ENT Devices Market is projected to register a CAGR of 6.40% during the forecast period (2024-2029)

Cochlear Ltd, Medtronic PLC, Olympus Corporation, Stryker Corporation and Sivantos Group (Signia) are the major companies operating in the Global ENT Devices Market.

ENT Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)